Atara Biotherapeutics, Inc. (ATRA) analyst actions

Rating and price-target actions on ATRA in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ATRA overview →

6 measured ATRA analyst action events.

DateHeadlineEvent5-minTo close
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation Into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Reach OutPress release-0.85%-0.42%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Reach OutPress release—-0.58%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Reach OutPress release+0.00%-1.15%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Reach OutPress release—+3.99%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Reach OutPress release+1.53%+7.44%
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Reach OutPress release+1.33%+11.47%
Get an email when ATRA moves on news →
Keep exploring

More ATRA: earnings → · SEC filings → · ATRA overview →

Other Healthcare names and their analyst actions

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.